Status:
WITHDRAWN
Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis
Lead Sponsor:
Boston Children's Hospital
Conditions:
Appendicitis Acute
Eligibility:
All Genders
8-17 years
Phase:
PHASE1
Brief Summary
This study evaluates the ability of contrast-enhanced ultrasound to improve the diagnosis of acute appendicitis in children compared to conventional ultrasound.
Detailed Description
Acute appendicitis is the most common surgical emergency in children. Diagnostic evaluation for possible appendicitis frequently leads to imaging studies. Magnetic resonance imaging (MRI) and computed...
Eligibility Criteria
Inclusion
- Children who have had a conventional abdominal US study to rule out acute appendicitis and are scheduled for an MRI or CT examination.
Exclusion
- Children with serious comorbid conditions, including but not restricted to severe cardiac, pulmonary, renal, or hepatic disease; prior bone marrow or solid organ transplant; cancer; or presence of a ventriculoperitoneal shunt.
- Children with an allergy to either the active or inactive components of Lumason.
- Pregnant or nursing patients.
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03295656
Start Date
July 15 2020
End Date
July 15 2020
Last Update
July 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115